Lachlan L. Dalli is a PhD Candidate and Research Assistant from the Stroke and Ageing Research Group, Monash University. He has a background in Biomedical Science and extensive experience in epidemiology, statistics, and public health research. He has contributed to >8 peer-reviewed publications in scientific journals, >5 online reports, and >200 individualised hospital reports to support the direct translation of evidence to improve stroke care in Australia. Lachlan's current research involves analysis of linked data from the Australian Stroke Clinical Registry and the Pharmaceutical Benefits Scheme. Using these comprehensive data sources, Lachlan aims to determine outcomes associated with medication adherence after stroke to inform policy and practice within Australia, and internationally.

Professor Stephen Davis is the Professor of Translational Neuroscience at the University of Melbourne, Director of the Melbourne Brain Centre at the Royal Melbourne Hospital and a Past-President of the World Stroke Organization. He co-chairs the Australian Stroke Alliance, the Melbourne Mobile Stroke Unit program and the Australian Chinese Training Initiative of Neurology. He is a Past-President of the Australian and New Zealand Association of Neurologists and the Stroke Society of Australasia. He has received numerous awards including the 2011 William Feinberg Award from the American Stroke Association, the Bethlehem Griffiths Foundation Research Medal in 2011, the 2012 E Graeme Robertson award of the Australian and New Zealand Association of Neurologists, the 2012 Karolinska Award and the 2014 JJ Wepfer Award from the European Stroke Council, 2018 Stroke Leadership Award from the World Stroke Organization and the 2019 Chinese Stroke Association International Cooperation Award. He was elected as an inaugural Fellow in the Australian Academy of Health and Medical Sciences in 2015 and was the 2017 C Miller Fisher Visiting Professor at the Massachusetts General Hospital/Harvard. In 2021 he was appointed an Officer of the Order of Australia. His research is focused on acute therapy for both ischemic stroke and intracerebral haemorrhage, particularly the use of advanced imaging in selection of therapy. He is a consulting editor for Stroke and serves on editorial boards of the International Journal of Stroke, the European Stroke Journal and the Journal of Clinical Neuroscience. He is the Principal Investigator of an NHMRC stroke program grant 2017-2021 and a MRFF grant on use of tranexamic acid in the mobile stroke unit for intracerebral hemorrhage. He is the Co-Lead (with G Donnan) of the 2021 Frontiers MRFF grant on Pre-Hospital Stroke Care. He has an h-index of 100, has co-authored three books, numerous book chapters, and more than 550 peer-reviewed research papers.

Jesse Dawson is a Professor of Stroke Medicine at the Institute of Cardiovascular and Medical Sciences and Associate at the School of Medicine, Dentistry and Nursing, University of Glasgow. Professor Dawson is a Consultant Physician in the Queen Elizabeth University Hospital, Glasgow. He is Clinical Lead for the Scottish Stroke Research Network and recently chaired the European Stroke Organization Conference. Professor Dawson has research interests in clinical trials on prevention and rehabilitation in stroke survivors, with special focus on improving long-term outcomes.

I am a cognitive neuropsychologist, with 16 years of research experience working at the interface between cognitive neuropsychology and clinical practice in stroke. Since 2015, I head the Translational Neuropsychology Research Group at the University of Oxford. My research thus far has spanned fundamental cognitive neuropsychology, clinical tool development for cognitive screening, and observational cohort studies capitalising on real-world clinical cohort data, including routinely acquired clinical brain scans. I completed my PhD in neuropsychology at the University of Birmingham (2010) followed by a postdoctoral position at Birmingham and the University of Oxford. I received the Lord Leonard and Lady Estelle Wolfson Stroke Association lectureship, and started my independent lab, the Translational Neuropsychology Group at the University of Oxford in 2015. I was recently awarded the Stroke Association’s Priority Programme Award (2019) to investigate long term psychological consequences of stroke. The biggest impact of my work so far has been the implementation of the Oxford Cognitive screen (www.ocs-test.org), developed specifically for stroke and now licenced to over 1200 clinical stroke settings. More info on current projects in the lab: www.demeyerelab.org

Martin became interested in stroke when he joined Charles Warlow, Peter Sandercock and John Bamford on the Oxfordshire Community Stroke Project in 1985 and completed an MD thesis on the incidence and prognosis of TIAs. Having completed his clinical training in Oxford in 1990 he was appointed as a Senior Lecturer in Stroke medicine and honorary consultant physician in Edinburgh (rejoining Charles and Peter who had moved there in 1987/8) and subsequently was appointed to a personal chair. He has established stroke services in Edinburgh, initiated the Scottish Stroke Care Audit and was founding president of the British Association of Stroke Physicians (BASP). He was chief investigator of the FOOD (I, 2 and 3), CLOTS (I, 2 and 3) and FOCUS randomised controlled trials. He was a member of the ESO group preparing TIA guidelines. He is currently Specialty advisor the the Chief Medical Officer in Scotland and clinical lead for the Scottish Governments Programme for government for stroke.